Product
GIP(1-42)
1 clinical trial
1 indication
Indication
Increntin EffectClinical trial
The Effect of Glucose-dependent Insulinotropic Polypeptide (GIP), Glucagon-like Peptide-1 (GLP-1) and Glucagon-like Peptide-2 (GLP-2) in Individuals With Genetically Altered Receptor FunctionStatus: Recruiting, Estimated PCD: 2027-12-01